Form 4: Coherus CFO's Stock Transaction for Tax Liability

Coherus Oncology's CFO, Bryan J. McMichael, reported the disposition of 1,715 shares of common stock to cover tax liabilities related to RSU vesting.

Summary

• Bryan J. McMichael, Chief Financial Officer of Coherus Oncology, Inc. (CHRS), reported a transaction involving the company's common stock.
• On January 20, 2026, 1,715 shares of common stock were disposed of.
• This disposition was not a sale by Mr. McMichael but represented shares automatically withheld by Coherus Oncology to satisfy tax obligations arising from the vesting of restricted stock units.
• The shares were valued at $1.55 for tax purposes.
• Following this transaction, Mr. McMichael beneficially owns 21,236 shares of Coherus Oncology common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding event related to RSU vesting, not indicative of management's sentiment towards the company's future performance or operational changes.

Positives

• The transaction was for tax withholding purposes related to the vesting of restricted stock units, not a direct discretionary sale by the Chief Financial Officer, which typically does not signal a lack of confidence.

Negatives

• No direct negatives are indicated by this routine tax-related transaction.

Risks

• No new risks are identified in this filing.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary tax withholding event related to executive compensation.

Key Dates

Recommendation

This Form 4 reports a routine tax withholding transaction related to the vesting of restricted stock units for the Chief Financial Officer. It does not reflect a discretionary sale or purchase by the insider, and therefore provides no new information to alter an existing investment thesis for Coherus Oncology.

Keywords

Coherus Oncology, CHRS, Form 4, insider transaction, stock disposition, tax withholding, restricted stock units, RSU vesting, Bryan J. McMichael, Chief Financial Officer